Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy of AL vs DP for Uncomplicated Malaria in Kenyan Children
NCT05060198Completed
- Sponsor
- Kenya Medical Research Institute
- Start
- Jun 2016
- Primary completion
- Mar 2017
- Modality
- Bivalent/Multivalent Binders, Nucleic Acid-Directed Small Molecules, Orthosteric Ligands
01
Overview
Randomised, open-label trial in Plasmodium falciparum malaria comparing Artemether-lumefantrine with Dihydroartemisinin-piperaquine (2 arms). Primary endpoints: Adequate Clinical and Parasitological Response at 42 days, Early Treatment Failure at 3 days and 2 more. Started Jun 2016; status: completed.
02
Drugs
artemether + lumefantrinedihydroartemisinin + piperaquine
03
Conditions
Plasmodium falciparum malaria
Beyond the preview
Go deeper on NCT05060198.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05060198.